Insufficient scRNA-seq data for expression of IFNA5 at single-cell level.
Insufficient scRNA-seq data for expression of IFNA5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
blood vessel | 64% | 2.78 | 861 / 1335 | 0% | 0 | 0 / 0 |
lung | 64% | 2.81 | 369 / 578 | 0% | 0.00 | 2 / 1155 |
adrenal gland | 55% | 1.83 | 141 / 258 | 0% | 0.01 | 1 / 230 |
intestine | 54% | 2.14 | 526 / 966 | 0% | 0 | 0 / 527 |
spleen | 54% | 2.04 | 130 / 241 | 0% | 0 | 0 / 0 |
uterus | 52% | 1.79 | 89 / 170 | 0% | 0 | 0 / 459 |
esophagus | 47% | 1.80 | 681 / 1445 | 0% | 0 | 0 / 183 |
adipose | 47% | 1.66 | 565 / 1204 | 0% | 0 | 0 / 0 |
breast | 46% | 1.67 | 209 / 459 | 1% | 0.01 | 6 / 1118 |
kidney | 44% | 1.37 | 39 / 89 | 0% | 0.00 | 1 / 901 |
prostate | 43% | 1.39 | 105 / 245 | 0% | 0 | 0 / 502 |
thymus | 42% | 1.25 | 276 / 653 | 0% | 0 | 0 / 605 |
brain | 40% | 1.50 | 1070 / 2642 | 0% | 0.01 | 1 / 705 |
stomach | 39% | 1.17 | 141 / 359 | 0% | 0 | 0 / 286 |
skin | 38% | 1.26 | 696 / 1809 | 0% | 0 | 0 / 472 |
bladder | 38% | 1.05 | 8 / 21 | 0% | 0 | 0 / 504 |
muscle | 38% | 1.14 | 305 / 803 | 0% | 0 | 0 / 0 |
ovary | 35% | 1.08 | 63 / 180 | 0% | 0 | 0 / 430 |
heart | 32% | 0.84 | 276 / 861 | 0% | 0 | 0 / 0 |
pancreas | 25% | 0.72 | 83 / 328 | 0% | 0 | 0 / 178 |
liver | 20% | 0.57 | 46 / 226 | 0% | 0.00 | 1 / 406 |
peripheral blood | 18% | 0.48 | 163 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0002250 | Biological process | adaptive immune response |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0098586 | Biological process | cellular response to virus |
GO_0042100 | Biological process | B cell proliferation |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0051607 | Biological process | defense response to virus |
GO_0033141 | Biological process | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO_0002323 | Biological process | natural killer cell activation involved in immune response |
GO_0030183 | Biological process | B cell differentiation |
GO_0002286 | Biological process | T cell activation involved in immune response |
GO_0006959 | Biological process | humoral immune response |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005126 | Molecular function | cytokine receptor binding |
GO_0005132 | Molecular function | type I interferon receptor binding |
GO_0005125 | Molecular function | cytokine activity |
Gene name | IFNA5 |
Protein name | Interferon alpha-5 (IFN-alpha-5) (Interferon alpha-61) (Interferon alpha-G) (LeIF G) Interferon 1AA9 (Interferon, alpha 5) |
Synonyms | hCG_1741707 IF1AA9 |
Description | FUNCTION: Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. |
Accessions | P01569 ENST00000610521.2 A0A7R8C382 |